The role of influenza vaccination in the COVID-19 infection: Impact on incidence and severity in Iraq

Ahmed Mohammed Taqi Al Mosawi Haitham Mahmood KadhimHussam Majeed Hameed   

Open Access   

Published:  Jun 21, 2022

Abstract

Influenza vaccine was found to have cross-protective effects against heterologous illnesses, so the role of the influenza vaccination in COVID-19 infection is examined. A total of 1475 participants were separated into 2 groups: 194 individuals who got the influenza vaccination and 1,281 that did not. A comparison of positive COVID-19 testing was the primary outcome. From the two groups, 52 patients who got the influenza vaccination and 50 patients who did not get the vaccination were selected to predict the severity of the COVID-19 infection. The results showed that 13.15% of the participants received the influenza vaccine and no significant difference in the COVID-19 infection rates between the two groups was noted (odds ratio = 1.20, 95% CI = 0.890–1.630, p-value ≤ 0.05). In the vaccinated group, outcomes determined a nonsignificant decrease in the infected odds compared to noninfected, while a significant decrease was shown in the unvaccinated group. Finally, only 1 out of 52 patients (1.9%) in the vaccinated group required oxygen therapy or hospitalization versus 9 out of 50 patients (18%) in the unvaccinated group (odds ratio = 0.08, 95% CI = 0.01–0.7, p-value ≤ 0.05). Influenza vaccination could be linked to better clinical outcomes and a lower COVID-19 severity score, without significant effect on the infection rate.


Keyword:     COVID-19 influenza influenza vaccination coronavirus SARS-CoV-2.


Citation:

Al Mosawi AMT, Kadhim HM, Hameed HM. The role of influenza vaccination in the COVID-19 infection: Impact on incidence and severity in Iraq. J Appl Pharm Sci, 2022. Online First.

Copyright: © The Author(s). This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

HTML Full Text

Reference

Agrawal B. Heterologous immunity: role in natural and vaccineinduced resistance to infections. Front Immunol, 2019; 10:164. https://doi.org/10.3389/fimmu.2019.02631

Amato M, Werba JP, Frigerio B, Coggi D, Sansaro D, Ravani A, Ferrante P, Veglia F, Tremoli E, Baldassarre D. Relationship between influenza vaccination coverage rate and COVID-19 outbreak: an Italian Ecological Study. Vaccines (Basel), 2020; 8(3). https://doi.org/10.3390/vaccines8030535

Arokiaraj MC. Correlation of influenza vaccination and influenza incidence on COVID-19 severity and other perspectives. SSRN, Rochester, NY, 2020. https://doi.org/10.2139/ssrn.3572814

Chan JF, Kok KH, Zhu Z, Chu H, To KK, Yuan S. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect, 2020; 9:221-36. https://doi.org/10.1080/22221751.2020.1719902

Consortium E. COVID-19 Severity in Europe and the USA: Could the seasonal influenza vaccination play a role? SSRN, Rochester, NY, 2020. https://doi.org/10.2139/ssrn.3621446

Cowling B.J., Nishiura H. Virus interference and estimates of influenza vaccine effectiveness from test-negative studies. Epidemiology, 2012; 23(6):930-1. https://doi.org/10.1097/EDE.0b013e31826b300e

Cowling BJ, Fang VJ, Nishiura H, Chan KH, Sophia Ng, Dennis K M Ip, Chiu SS, Leung GM, Peiris JSM. Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine. Clin Infect Dis, 2012; 54:1778-83. https://doi.org/10.1093/cid/cis307

Debisarun PA, Struycken P, Domínguez-Andrés J, Moorlag SJCFM, Taks E, Gössling KL, Ostermann PN, Müller L, Schaal H, ten Oever J, van Crevel R, Netea MG. The effect of influenza vaccination on trained immunity: impact on COVID-19. medRxiv.

Feng S, Fowlkes A, Steffens A, Finelli L, Cowling B. Assessment of virus interference in a test-negative study of influenza vaccine effectiveness. Epidemiology, 2017; 28(4):514-24. https://doi.org/10.1097/EDE.0000000000000670

Fink G, Orlova-Fink N, Schindler T, Grisi S, Ferrer AP, Daubenberger C, Brentani A. Inactivated trivalent influenza vaccine is associated with lower mortality among COVID-19 patients in Brazil. BMJ Evid Based Med, 2020. https://doi.org/10.1101/2020.06.29.20142505

Goodridge HS, Ahmed SS, Curtis N, Kollmann TR, Levy O, Netea MG, Pollard AJ, Van Crevel R, Wilson CB. Harnessing the beneficial heterologous effects of vaccination. Nat Rev Immunol, 2016; 16(6):392- 400. https://doi.org/10.1038/nri.2016.43

Hashemi SA, Safamanesh S, Ghafouri M, Taghavi MR, Mohajer Zadeh Heydari MS, Namdar Ahmadabad H. Co-infection with COVID-19 and influenza A virus in two died patients with acute respiratory syndrome, Bojnurd. Iran. J Med Virol, 2020. https://doi.org/10.1002/jmv.26014

Isaacs A, Lindenmann J. Virus interference. I. The interferon. Proc R Soc Lond Ser B Biol Sci, 1957; 147(927):258-67. https://doi.org/10.1098/rspb.1957.0048

Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM, Reed C, Grijalva CG, Anderson EJ, Courtney DM, Chappell JD, Qi C, Hart EM, Carroll F, Trabue C, Donnelly HK, Williams DJ, Zhu Y, Arnold SR, Ampofo K, Waterer GW, Levine M, Lindstrom S, Winchell JM, Katz JM, Erdman D, Schneider E, Hicks LA, McCullers JA, Pavia AT, Edwards KM, Finelli L, CDC EPIC Study Team. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med, 2015; 373:415-27. https://doi.org/10.1056/NEJMoa1500245

Kleinnijenhuis J, Quintin J, Preijers F, Joosten LAB, Ifrim DC, Saeed S, Jacobs C, Loenhout J, Jong D, Stunnenberg HG, Xavier RJ, van der Meer JWM, van Crevel R, Netea MG. Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc Natl Acad Sci USA, 2012; 109(43):17537-42. https://doi.org/10.1073/pnas.1202870109

Kostas D, Laure F, Scarlett G, Côme D, Sibylle BS, Lisa D. High impact of COVID-19 in long-term care facilities, suggestion for monitoring in the EU/EEA, May 2020. Euro Surveill, 2020; 25(22). https://doi.org/10.2807/1560-7917.ES.2020.25.22.2000956

Lisewski A M, Association between Influenza Vaccination Rates and SARS-CoV-2 Outbreak Infection Rates in OECD Countries. SSRN, 2020. https://doi.org/10.2139/ssrn.3558270

Lovato A, de Filippis C, Marioni G. Upper airway symptoms in coronavirus disease 2019 (COVID-19). Am J Otolaryngol, 2020; 102474. https://doi.org/10.1016/j.amjoto.2020.102474

Ma S, Lai X, Chen Z, Tu S, Qin K. Clinical characteristics of critically ill patients co-infected with SARS-CoV-2 and the influenza virus in Wuhan. China. Int J Infect Dis, 2020; 96:683-7. https://doi.org/10.1016/j.ijid.2020.05.068

Marín-Hernández D, Schwartz RE, Nixon DF. Epidemiological evidence for association between higher influenza vaccine uptake in the elderly and lower COVID-19 deaths in Italy. J Med Virol, 2020. https://doi.org/10.1002/jmv.26120

Moorlag S, Röring RJ, Joosten LAB, Netea MG. The role of the interleukin-1 family in trained immunity. Immunol Rev, 2018; 281(1):28-39. https://doi.org/10.1111/imr.12617

Netea MG, Domínguez-Andrés J, Barreiro LB, Chavakis TJ, Divangahi M, Fuchs E, Joosten LAB, Van der Meer JWM, Mhlanga MM, Mulder WJM, Riksen NP, Schlitzer A, Schultze JL, Benn CS, Sun JC, Xavier RJ, Latz E. Defining trained immunity and its role in health and disease. Nat Rev Immunol, 2020; 20(6):375-88. https://doi.org/10.1038/s41577-020-0285-6

Paranjpe I, Russak A, De Freitas JK, Lala A, Miotto R, Vaid A, Johnson KW, Danieletto M, Golden E, Meyer D, Singh M, Somani S, Manna S, Nangia U, Kapoor A, O'Hagan R, O'Reilly PF, Huckins LM, Glowe P, Kia A, Timsina P, Freeman RM, Levin MA, Jhang J, Firpo A, Kovatch P, Finkelstein J, Aberg JA, Bagiella E, Horowitz CR, Murphy B, Fayad ZA, Narula J, Nestler EJ, Fuster V, Cordon-Cardo C, Charney DS, Reich DL, Just AC, Bottinger EP, Charney AW, Glicksberg BS, Nadkarni GN. Clinical characteristics of hospitalized COVID-19 patients in New York City. medRxiv. 2020. https://doi.org/10.1101/2020.04.19.20062117

Pascarella G, Strumia A, Piliego C, Bruno F, Del Buono R,Costa F, Scarlata S, Agrò FE. COVID-19 diagnosis and management: a comprehensive review. J Intern Med, 2020; 288(2):192-206. https://doi.org/10.1111/joim.13091

Pawlowski C, Puranik A, Bandi H, Venkatakrishnan AJ, Agarwal V, Kennedy R, O'Horo JC, Gores GJ, Williams AW, Halamka J. Exploratory analysis of immunization records highlights decreased SARSCoV-2 rates in individuals with recent non-COVID-19 vaccinations. Sci Rep, 2021; 11(1):4741. https://doi.org/10.1038/s41598-021-83641-y

Petrilli CM, Jones SA, Yang J, Rajagopalan H, O' Donnell L, Chernyak Y. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. Br Med J; 2020; 22(369):m1966. https://doi.org/10.1136/bmj.m1966

Petrovsky N. Comparative safety of vaccine adjuvants: a summary of current evidence and future needs. Drug Saf, 2015; 38(11):1059-74. https://doi.org/10.1007/s40264-015-0350-4

Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, Xie C, Ma K, Shang K, Wang W. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis, 2020; 71(15):762-8. https://doi.org/10.1093/cid/ciaa248

Ramaiah A, Arumugaswami V. Insights into cross-species evolution of novel human coronavirus 2019-nCoV and defining immune determinants for vaccine development. bioRxiv. 2020 Jan 30. https://doi.org/10.1101/2020.01.29.925867

Rikin S, Jia H, Stockwell M. Assessment of temporally-related acute respiratory illness following influenza vaccination. Vaccine, 2018; 36:1958-64. https://doi.org/10.1016/j.vaccine.2018.02.105

Seppälä E, Viskari H, Hoppu S, Honkanen H, Huhtala H, Simell O, Ilonen J, Knip M, Hyöty H. Viral interference induced by live attenuated virus vaccine (OPV) can prevent otitis media. Vaccine, 2011; 29(47):8615-8. https://doi.org/10.1016/j.vaccine.2011.09.015

Sundaram ME, McClure DL, Belongia EA. Influenza vaccination is not associated with detection of noninfluenza respiratory viruses in seasonal studies of influenza vaccine effectiveness. Clin Infect Dis, 2013; 57:789-93. https://doi.org/10.1093/cid/cit379

Suzuki M., Camacho A., Ariyoshi K. Potential effect of virus interference on influenza vaccine effectiveness estimates in test-negative designs. Epidemiol Infect, 2014; 142:2642-6. https://doi.org/10.1017/S0950268814000107

Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring HarbPerspect Biol, 2014; 6(10):a016295. https://doi.org/10.1101/cshperspect.a016295

Wolff GG. Influenza vaccination and respiratory virus interference among Department of Defense personnel during the 2017- 2018 influenza season. Vaccine, 2020; 38(2):350-4. https://doi.org/10.1016/j.vaccine.2019.10.005

Wu A, Peng Y, Huang B, Ding X, Wang X, Niu P. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe, 2020; 27:325-8. https://doi.org/10.1016/j.chom.2020.02.001

Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for disease control and prevention. JAMA, 2020. https://doi.org/10.1001/jama.2020.2648

Zanettini, C. Omar M, Dinalankara W, Imada EL, Colantuoni E, Parmigiani G, Marchionni L. Influenza vaccination and COVID-19 mortality in the USA: an Ecological study. Vaccines, 2021; 9(5):427. https://doi.org/10.3390/vaccines9050427

Zhu J, Zhong Z, Ji P, Li H, Li B, Pang J, Zhang J, Zhao C. Clinicopathological characteristics of 8697 patients with COVID-19 in China: a meta-analysis. Fam Med Commun Health, 2020; 8(2):e000406. https://doi.org/10.1136/fmch-2020-000406

Article Metrics

0 Absract views 0 PDF Downloads 0 Total views

   Abstract      Pdf Download

Related Search

By author names

Citiaion Alert By Google Scholar

Name Required
Email Required Invalid Email Address

Comment required